Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia

In this report, a case of relapsed Ph+ ALL was remedied by reinduction, and consolidation regimen of TKI and Flu+ Ara‐C+ IDA (FLAI) combination, followed by haploidentical SCT. Results suggest that FLAI together with TKI and subsequently with haploidentical SCT could be applied for relapsed Ph+ ALL....

Descripción completa

Detalles Bibliográficos
Autores principales: Sang, Wei, Wang, Ying, Zhang, Cong, Yan, Dongmei, Niu, Mingshan, Yang, Chun, Liu, Xia, Sun, Cai, Zhang, Zhe, Loughran, Thomas P., Xu, Kailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831391/
https://www.ncbi.nlm.nih.gov/pubmed/27099735
http://dx.doi.org/10.1002/ccr3.438
_version_ 1782427064287100928
author Sang, Wei
Wang, Ying
Zhang, Cong
Yan, Dongmei
Niu, Mingshan
Yang, Chun
Liu, Xia
Sun, Cai
Zhang, Zhe
Loughran, Thomas P.
Xu, Kailin
author_facet Sang, Wei
Wang, Ying
Zhang, Cong
Yan, Dongmei
Niu, Mingshan
Yang, Chun
Liu, Xia
Sun, Cai
Zhang, Zhe
Loughran, Thomas P.
Xu, Kailin
author_sort Sang, Wei
collection PubMed
description In this report, a case of relapsed Ph+ ALL was remedied by reinduction, and consolidation regimen of TKI and Flu+ Ara‐C+ IDA (FLAI) combination, followed by haploidentical SCT. Results suggest that FLAI together with TKI and subsequently with haploidentical SCT could be applied for relapsed Ph+ ALL.
format Online
Article
Text
id pubmed-4831391
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-48313912016-04-20 Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia Sang, Wei Wang, Ying Zhang, Cong Yan, Dongmei Niu, Mingshan Yang, Chun Liu, Xia Sun, Cai Zhang, Zhe Loughran, Thomas P. Xu, Kailin Clin Case Rep Case Reports In this report, a case of relapsed Ph+ ALL was remedied by reinduction, and consolidation regimen of TKI and Flu+ Ara‐C+ IDA (FLAI) combination, followed by haploidentical SCT. Results suggest that FLAI together with TKI and subsequently with haploidentical SCT could be applied for relapsed Ph+ ALL. John Wiley and Sons Inc. 2016-03-04 /pmc/articles/PMC4831391/ /pubmed/27099735 http://dx.doi.org/10.1002/ccr3.438 Text en © 2016 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Sang, Wei
Wang, Ying
Zhang, Cong
Yan, Dongmei
Niu, Mingshan
Yang, Chun
Liu, Xia
Sun, Cai
Zhang, Zhe
Loughran, Thomas P.
Xu, Kailin
Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title_full Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title_fullStr Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title_full_unstemmed Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title_short Fludarabine, idarubicin, and cytarabine regimen together with TKI followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed Ph+ acute lymphoblastic leukemia
title_sort fludarabine, idarubicin, and cytarabine regimen together with tki followed by haploidentical hematopoietic stem cell transplantation, a success for relapsed ph+ acute lymphoblastic leukemia
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831391/
https://www.ncbi.nlm.nih.gov/pubmed/27099735
http://dx.doi.org/10.1002/ccr3.438
work_keys_str_mv AT sangwei fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT wangying fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT zhangcong fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT yandongmei fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT niumingshan fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT yangchun fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT liuxia fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT suncai fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT zhangzhe fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT loughranthomasp fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia
AT xukailin fludarabineidarubicinandcytarabineregimentogetherwithtkifollowedbyhaploidenticalhematopoieticstemcelltransplantationasuccessforrelapsedphacutelymphoblasticleukemia

Ejemplares similares